Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Video Abstracts
Reviews
Reviews
View all reviews ...
Review Series
Microbiome in Health and Disease (Feb 2025)
Substance Use Disorders (Oct 2024)
Clonal Hematopoiesis (Oct 2024)
Sex Differences in Medicine (Sep 2024)
Vascular Malformations (Apr 2024)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Reviews
Viewpoints
100th anniversary
Top read articles
LYSOLECITHIN AND HEMOLYTIC ANEMIA. THE SIGNIFICANCE OF LYSOLECITHIN PRODUCTION IN THE DIFFERENTIATION OF CIRCULATING AND STAGNANT BLOOD
Karl Singer
Karl Singer
Published March 1, 1941
Citation Information:
J Clin Invest.
1941;
20(2)
:153-160.
https://doi.org/10.1172/JCI101207
.
View:
Text
|
PDF
Research Article
LYSOLECITHIN AND HEMOLYTIC ANEMIA. THE SIGNIFICANCE OF LYSOLECITHIN PRODUCTION IN THE DIFFERENTIATION OF CIRCULATING AND STAGNANT BLOOD
Text
PDF
Abstract
Authors
Karl Singer
×
Other pages:
153
154
155
156
157
158
159
160
Other pages:
153
154
155
156
157
158
159
160
